Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 161 entries
View as:

Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06659042 Org: User:
Start: 11/20/24 End: 11/20/27 Due: 11/20/28

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02975609 Org: User:
Start: 11/30/16 End: 12/31/20 Due: 12/31/21

Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT06348381 Org: User:
Start: 04/01/24 End: 12/31/25 Due: 12/31/26

EBUS Image Features in the Diagnosis of PPLs

Phase: N/A Priority: Normal
NCT ID: NCT03575715 Org: User:
Start: 07/31/18 End: 12/31/19 Due: 12/31/20

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02938546 Org: User:
Start: 11/30/16 End: 01/31/23 Due: 01/31/24

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06456138 Org: User:
Start: 07/01/24 End: 12/31/28 Due: 12/31/29

Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

Phase: N/A Priority: Normal
NCT ID: NCT06469060 Org: User:
Start: 06/19/24 End: 06/30/27 Due: 06/30/28

Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia

Phase: N/A Priority: Normal
NCT ID: NCT05021627 Org: User:
Start: 09/01/21 End: 08/31/26 Due: 08/31/27

First-line Combination Treatment Based on Anlotinib

Phase: N/A Priority: Normal
NCT ID: NCT03628521 Org: User:
Start: 07/20/18 End: 12/31/20 Due: 12/31/21

Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05218759 Org: User:
Start: 02/21/22 End: 10/31/25 Due: 10/31/26

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

Phase: N/A Priority: Normal
NCT ID: NCT04489004 Org: User:
Start: 08/01/20 End: 12/01/22 Due: 12/01/23

A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT06460831 Org: User:
Start: 06/15/24 End: 12/31/24 Due: 12/31/25

The Novel Special Light for Endotracheal/Bronchial Lesions.

Phase: N/A Priority: Normal
NCT ID: NCT07036614 Org: User:
Start: 01/31/24 End: 09/30/26 Due: 09/30/27

A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06936644 Org: User:
Start: 04/30/25 End: 03/30/28 Due: 03/30/29

Diagnostic Value of UTB and TB for PPL

Phase: N/A Priority: Normal
NCT ID: NCT04571476 Org: User:
Start: 03/08/21 End: 07/31/22 Due: 07/31/23

RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06012214 Org: User:
Start: 01/01/24 End: 12/31/28 Due: 12/31/29

Sd-RAB for the Diagnosis of PPLs

Phase: N/A Priority: Normal
NCT ID: NCT06719687 Org: User:
Start: 12/31/24 End: 02/28/25 Due: 02/28/26

The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO

Phase: N/A Priority: Normal
NCT ID: NCT04727190 Org: User:
Start: 03/01/21 End: 12/30/21 Due: 12/30/22

ENB for the Diagnosis of PPNs:a Real World Study

Phase: N/A Priority: Normal
NCT ID: NCT03716284 Org: User:
Start: 03/20/19 End: 06/30/22 Due: 06/30/23

Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05103501 Org: User:
Start: 12/01/21 End: 09/30/24 Due: 09/30/25

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04135664 Org: User:
Start: 09/01/19 End: 12/01/27 Due: 12/01/28

Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-inferiority Trial

Phase: N/A Priority: Normal
NCT ID: NCT06548451 Org: User:
Start: 08/15/24 End: 12/30/25 Due: 12/30/26

Catheter Ablation of Longstanding Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02929836 Org: User:
Start: 05/31/16 End: 10/31/18 Due: 10/31/19

Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study

Phase: N/A Priority: Normal
NCT ID: NCT04597346 Org: User:
Start: 12/23/21 End: 06/30/24 Due: 06/30/25

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Phase: N/A Priority: Normal
NCT ID: NCT04197076 Org: User:
Start: 02/25/19 End: 12/31/24 Due: 12/31/25